Organization
MorphoSys AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
MorphoSys AG
... up by spending €95 million upfront to take charge of Galapagos and MorphoSys' atopic dermatitis drug, before Gilead's Kite Pharma completed the series by bagging ...
... Tremfya is looking to follow in the footsteps of its big brother. MorphoSys, partnered with the New Jersey drugmaker's Janssen unit, said Tuesday that the ...
... Program (GALAXI) to Evaluate Tremfya(R) (Guselkumab) in Crohn's Disease DGAP-News: MorphoSys AG / Key word(s): Study/Miscellaneous MorphoSys Announces its Licensee Janssen has Initiated ...
... in Chronic Lymphocytic Leukemia at EHA 2018 Conference DGAP-News: MorphoSys AG / Key word(s): Study results MorphoSys Presents Clinical Data with Blood ...
... in Early Alzheimer's Disease now Underway DGAP-News: MorphoSys AG / Key word(s): Study New Phase 3 Clinical Trials by MorphoSys's ...
... DGAP-News: present at the following conferences: MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) will MorphoSys to ...
... MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR; OTC: MPSYY) announced today ...
... Blood Cancer Programs at Upcoming EHA 2018 Conference DGAP-News: MorphoSys AG / Key word(s): Conference/Study results MorphoSys Announces Presentation of Clinical Data ...
... DGAP-News: MorphoSys AG / Key word(s): Quarter Results CEST (1:00pm BST/8:00am EDT) Conference call ...
... Act] with the objective of Europe-wide distribution DGAP Total Voting Rights Announcement: MorphoSys AG / Total Voting Rights Announcement MorphoSys AG: Release according to Article ...
Subscribe now for full coverage on MorphoSys AG
Start My Free Trial